Roquefort Therapeutics plc (ROQ)
Market Closed
20 Jul, 15:30
LSE LSE Primary 10. 50
GBX +0.5
+5%
155.54K Market Cap
- P/E Ratio
- Div Yield
1,000 Volume
- Eps
10 GBX
Previous Close Want to track ROQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Roquefort Therapeutics plc (ROQ) Statistics
Valuation metrics
Market Cap 155.54K
Enterprise value 218.52K
Trailing P/E (ttm) -0.13
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.03
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.2
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 91.67K
Average volume (90 days) 214.81K
Price summary
52-Week low 0.95
52-Week high 30
Beta -
50-Day moving average 10.19
200-Day moving average 5.51
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 27 Mar 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.17%
Return on equity -0.19%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.08
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.03
Total debt (mrq) -
Total Debt/Equity (mrq) 0.08
Current ratio (mrq) 0.63%
Book value per share (mrq) 0.38
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
